No insider bought or sold Aptose Biosciences Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow APTO

APTO over the last year

Prices for APTO aren't in yet.

APTO after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

13 insider filings since 2019, newest first

APTOBuy

Bernd R. Seizinger · Director

$53KSep 25

APTOBuy

Rafael Bejar · SVP and Chief Medical Officer

$26KNov 19

APTOSell

Donald R. Wilson Jr. · 10% owner

$157K−1.0%Aug 5

APTOBuy

Donald R. Wilson Jr. · 10% owner

$151K+1.0%Aug 5

APTOSell

Warren Whitehead · Director

$83K−63.0%Jun 23

APTOSell

Warren Whitehead · Director

$81K−33.0%Dec 28

APTOSell

Gregory K. Chow · EVP and CFO

$766K−35.0%Jul 10

APTOSell

William G. Rice · Chair, Pres, CEO

$1.0M−36.0%Jul 10

APTOSell

Jotin Marango · SVP, Chief Bus. Officer

$380K−35.0%Jul 10

APTOSell

Jotin Marango · SVP, Chief Bus. Officer

$133K−10.0%Jul 2

APTOSell

Warren Whitehead · Director

$243K−47.0%Jun 25

APTOBuy

Erich Platzer · Director

$44K+17.0%Mar 21

APTOBuy

Gregory K. Chow · SVP and CFO

$26K+13.0%Mar 14

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.